s6y

Apimeds Pharmaceuticals US, Inc.

Ticker
APUS
CIK
1894525
Industry
Pharmaceutical Preparations

Financials 14

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  7. 10-Q Quarterly Report for period ending Sep 30, 2025
  8. 10-Q Quarterly Report for period ending Jun 30, 2025
  9. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2025
  10. 10-Q Quarterly Report for period ending Mar 31, 2025

All 14 financials filings

News 28

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 28 news filings

Ownership 38

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4/A Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 38 ownership filings

Prospectus 21

  1. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  2. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  3. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  6. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1/A General form of registration statement for all companies including face-amount certificate companies
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 21 prospectus filings

Proxies 3

  1. DEF 14A Definitive proxy statements
  2. DEFM14C Definitive information statement relating to merger or acquisition
  3. PREM14C Preliminary information statements relating to merger or acquisition

Other 28

  1. SCHEDULE 13D/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13D/A
  4. SCHEDULE 13G
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 28 other filings